or Try an Advanced Search...

    Technical Analysis for HLS - HLS Therapeutics Inc

    Grade Last Price % Change Price Change
    F 3.240 3.51% 0.110
    HLS closed down 2.49 percent on Wednesday, November 20, 2024, on 6.09 times normal volume. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Down Down Down
    Historical HLS trend table...
    Date Alert Name Type % Chg
    180 Bearish Setup Bearish Swing Setup 3.51%
    Volume Surge Other 3.51%
    Outside Day Range Expansion 3.51%
    Oversold Stochastic Weakness 3.51%
    NR7 Range Contraction 0.93%
    Narrow Range Bar Range Contraction 0.93%
    Oversold Stochastic Weakness 0.93%
    Down 3 Days in a Row Weakness 2.53%
    Down 4 Days in a Row Weakness 2.53%
    Down 5 Days in a Row Weakness 2.53%
    Older End-of-Day Signals for HLS ...

       Recent Intraday Alerts

    Alert Time
    Gapped Up (Partial) 26 minutes ago
    Up 3% 26 minutes ago
    Up 2% 26 minutes ago
    Up 1% 26 minutes ago
    Up 2% about 21 hours ago
    View Earlier Intraday Alerts

    Free Daily (Stock) Chart Reading

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Read My Charts!
    Configure default chart indicators
    HLS Chart by TradingView
    Basic chart:

    Profile

    HLS Therapeutics Inc., a specialty pharmaceutical company, acquires and commercializes pharmaceutical products in the specialty central nervous system and cardiovascular markets in Canada, the United States, and internationally. Its lead product is Clozaril, an atypical antipsychotic used in the treatment of schizophrenia. The company also holds the U.S. marketing rights of Absorica, a commercial stage dermatology product. HLS Therapeutics Inc. has a license agreement with Amarin Corporation plc to register, commercialize, and distribute Vascepa capsules in Canada. The company was founded in 2018 and is headquartered in Toronto, Canada.
    Classification
    Sector: Healthcare
    Industry: Drug Manufacturers - Specialty & Generic
    Keywords: Pharmaceutical Life Sciences Pharmaceutical Products

    Is HLS a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 5.48
    52 Week Low 3.0
    Average Volume 31,743
    200-Day Moving Average 3.775
    50-Day Moving Average 3.531
    20-Day Moving Average 3.405
    10-Day Moving Average 3.376
    Average True Range 0.179
    RSI (14) 35.90
    ADX 28.91
    +DI 18.435
    -DI 28.884
    Chandelier Exit (Long, 3 ATRs) 3.455
    Chandelier Exit (Short, 3 ATRs) 3.536
    Upper Bollinger Bands 3.784
    Lower Bollinger Band 3.026
    Percent B (%b) 0.14
    BandWidth 22.261
    MACD Line -0.108
    MACD Signal Line -0.070
    MACD Histogram -0.0382
    Fundamentals Value
    Market Cap 99.6 Million
    Num Shares 31.8 Million
    EPS -0.90
    Price-to-Earnings (P/E) Ratio -3.49
    Price-to-Sales 8.55
    Price-to-Book 2.89
    Dividend 0.16
    Dividend Yield 5.11%
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 3.385
    Resistance 3 (R3) 3.413 3.357 3.343
    Resistance 2 (R2) 3.357 3.292 3.343 3.328
    Resistance 1 (R1) 3.243 3.252 3.215 3.215 3.314
    Pivot Point 3.187 3.187 3.173 3.173 3.187
    Support 1 (S1) 3.073 3.122 3.045 3.045 2.946
    Support 2 (S2) 3.017 3.082 3.003 2.932
    Support 3 (S3) 2.903 3.017 2.918
    Support 4 (S4) 2.875